StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN)

StockNews.com assumed coverage on shares of Evogene (NASDAQ:EVGN) in a report published on Monday. The firm issued a sell rating on the biotechnology company’s stock.

Separately, Lake Street Capital lowered their target price on shares of Evogene from $30.00 to $12.00 and set a “buy” rating on the stock in a research note on Friday, August 23rd.

Evogene Trading Down 4.3 %

Evogene stock opened at $1.65 on Monday. Evogene has a 12 month low of $1.56 and a 12 month high of $10.40. The company has a market capitalization of $8.86 million, a price-to-earnings ratio of -0.42 and a beta of 1.43. The business’s fifty day simple moving average is $2.44 and its two-hundred day simple moving average is $4.52.

Evogene (NASDAQ:EVGN) last announced its quarterly earnings results on Thursday, August 22nd. The biotechnology company reported ($1.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.94). Evogene had a negative return on equity of 72.33% and a negative net margin of 210.26%. The firm had revenue of $0.91 million during the quarter.

Hedge Funds Weigh In On Evogene

A hedge fund recently bought a new stake in Evogene stock. Renaissance Investment Group LLC purchased a new position in Evogene Ltd. (NASDAQ:EVGN) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,000 shares of the biotechnology company’s stock, valued at approximately $31,000. 10.40% of the stock is currently owned by institutional investors.

About Evogene

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.